Free Trial

Drugs Made in America Acquisition (DMAAU) Competitors

Drugs Made in America Acquisition logo
$10.19 -0.02 (-0.20%)
As of 05/1/2025 03:55 PM Eastern

DMAAU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRU

Should you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry.

Drugs Made in America Acquisition vs.

A SPAC III Acquisition (NASDAQ:ASPCU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

In the previous week, A SPAC III Acquisition had 2 more articles in the media than Drugs Made in America Acquisition. MarketBeat recorded 3 mentions for A SPAC III Acquisition and 1 mentions for Drugs Made in America Acquisition. Drugs Made in America Acquisition's average media sentiment score of 1.87 beat A SPAC III Acquisition's score of 0.29 indicating that Drugs Made in America Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
A SPAC III Acquisition Neutral
Drugs Made in America Acquisition Very Positive

Company Net Margins Return on Equity Return on Assets
A SPAC III AcquisitionN/A N/A N/A
Drugs Made in America Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
A SPAC III AcquisitionN/AN/AN/AN/AN/A
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A

A SPAC III Acquisition and Drugs Made in America Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
A SPAC III AcquisitionN/AN/A
Drugs Made in America AcquisitionN/AN/A

Summary

A SPAC III Acquisition and Drugs Made in America Acquisition tied by winning 1 of the 2 factors compared between the two stocks.

Get Drugs Made in America Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMAAU vs. The Competition

MetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance SectorNASDAQ Exchange
Market CapN/A$187.75M$11.11B$7.92B
Dividend YieldN/AN/A5.77%4.22%
P/E RatioN/AN/A22.1018.54
Price / SalesN/AN/A26.31103.35
Price / CashN/AN/A17.6034.62
Price / BookN/AN/A2.674.25
Net IncomeN/AN/A$1.03B$248.18M
7 Day Performance0.30%-0.76%0.77%1.25%
1 Month Performance0.69%0.49%-0.17%3.76%
1 Year PerformanceN/A29.84%538.56%5.28%

Drugs Made in America Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMAAU
Drugs Made in America Acquisition
N/A$10.19
-0.2%
N/AN/A$0.00N/A0.002Positive News
ASPCU
A SPAC III Acquisition
N/A$10.23
+0.2%
N/AN/A$0.00N/A0.00N/ALockup Expiration
Positive News
AGBAW
AGBA Group
N/A$0.10
-5.4%
N/A-58.2%$0.00$38.55M0.00152Gap Down
AGNCP
AGNC Investment
N/A$24.66
+0.1%
N/A+5.6%$0.00$584M0.0050Short Interest ↓
AGNCO
AGNC Investment
N/A$24.98
-0.1%
N/A+1.5%$0.00$584M0.0050Positive News
AGNCN
AGNC Investment
N/A$25.40
-0.2%
N/A-0.1%$0.00$584M0.0050Short Interest ↓
AGNCM
AGNC Investment
N/A$24.43
-0.4%
N/A-0.7%$0.00$584M0.0050
AGNCL
AGNC Investment
N/A$25.10
+2.1%
N/A+7.5%$0.00$584M0.0050Short Interest ↓
News Coverage
ANSCW
Agriculture & Natural Solutions Acquisition
N/A$0.18
-0.1%
N/A-28.6%$0.00N/A0.00N/APositive News
Gap Down
ANSCU
Agriculture & Natural Solutions Acquisition
N/A$10.79
0.0%
N/A+4.2%$0.00N/A0.00N/APositive News
AITRU
AI Transportation Acquisition
N/A$11.24
flat
N/AN/A$0.00N/A0.00N/APositive News

Related Companies and Tools


This page (NASDAQ:DMAAU) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners